Document Type: CASE REPORT


1 Orthopedic research center, Shahid Kamyab Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Associated Professor of Orthopedic surgery, Orthopedic Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 Orthopedic Research Center, Shahid Kamyab Hospital, Mashhad University of Medical Sciences, Mashhad, Iran


Progressive osseous heteroplasia is a rare inherited disease that begins with skin ossification and proceeds into the deeper connective tissues. The disease should be distinguished from other genetic disorders of heterotopic ossification including fibrodysplasia ossificans progressiva (FOP) and Albright hereditary osteodystrophy (AHO). We report a case of progressive osseous heteroplasia in a twenty four years old male with a complaint of ankylosis of the entire upper left limb and digital cutaneous lesions and sparing of the other limbs and the axial skeleton. Absence of great toe malformation, presence of cutaneous ossification, dermal bone spicules extruding in fingers, and involvement of just left upper limb were unique findings in contrast with FOP diagnosis in this case. There is no effective treatment or prevention for POH. Awareness of diagnostic features is necessary in early diagnosis of POH.


Main Subjects

1. Kaplan FS, Craver R, MacEwen GD, Gannon FH, Finkel
G, Hahn G, et al. Progressive osseous heteroplasia: a
distinct developmental disorder of. J Bone Joint Surg
Am. 1994; 76(3):425-36.
2. Pignolo RJ, Ramaswamy G, Fong JT, Shore EM, Kaplan
FS. Progressive osseous heteroplasia: diagnosis,
treatment, and prognosis. Appl Clin Genet. 2015;
3. Seror R, Job-Deslandre C, Kahan A. Progressive
osseous heteroplasia: a rare case of late onset.
Rheumatology (Oxford). 2007; 46(4):716 -7.
4. Miller ES, Esterly NB, Fairley JA. Progressive osseous
heteroplasia. Arch Dermatol. 1996; 132(7):787-91.
5. Elli FM, Barbieri AM, Bordogna P, Ferrari P, Bufo
R, Ferrante E, et al. Screening for GNAS genetic
and epigenetic alterations in progressive osseous
heteroplasia: first Italian series. Bone. 2013;
6. Aynaci O, Mujgan Aynaci F, Cobanoglu U, Alpay K.
Progressive osseous heteroplasia. A case report and
review of the literature. J Pediatr Orthop B. 2002;
11(4):339 -42.
7. Singh GK, Verma V. Progressive osseous heteroplasia
in a 10-year-old male child. Indian J Orthop. 2011;
8. Santiago F, Vieira R, Cordeiro M, Tellechea O,
Figueiredo A. Unilateral progressive osseous
heteroplasia. Eur J Dermatol. 2009; 19(3):214-5.
9. Rodriguez-Jurado R, Gonzalez-Crussi F, Poznanski
AK. Progressive osseous heteroplasia, uncommon
cause of soft tissue ossification: a case report and
review of the literature. Pediatr Pathol Lab Med.
1995; 15(5):813-27.
10. Lin MH, Numbenjapon N, Germain-Lee EL,
Pitukcheewanont P. Progressive osseous
heteroplasia, as an isolated entity or overlapping
with Albright hereditary osteodystrophy. J Pediatr
Endocrinol Metab. 2015; 28(7-8):911-8.
11. Pgnolo RJ, Shore EM, Kaplan FS. Fibrodysplasia
ossificans progressiva: clinical and genetic aspects.
Orphanet J Rare Dis. 2011; 6(1):80.
12. Adegbite NS, Xu M, Kaplan FS, Shore EM, Pignolo RJ.
Diagnostic and mutational spectrum of progressive
osseous heteroplasia (POH) and other forms of
GNAS-based heterotopic ossification. Am J Med
Genet A. 2008; 146A(14):1788-96.
13. Schrander DE, Welting TJ, Caron MM, Schrander JJ,
van Rhijn LW, Körver-Keularts I, et al. Endochondral
ossification in a case of progressive osseous
heteroplasia in a young female child. J Pediatr Orthop
B. 2014; 23(5):477-84.
14. Goto M, Mabe H, Nishimura G, Katsumata N.
Progressive osseous heteroplasia caused by a novel
nonsense mutation in the GNAS1 gene. J Pediatr
Endocrinol Metab. 2010; 23(3):303-9.
15. Schimmel RJ, Pasmans SG, Xu M, Stadhouders-Keet
SA, Shore EM, Kaplan FS, et al. GNAS-associated
disorders of cutaneous ossification: two different
clinical presentations. Bone. 2010; 46(3):868-72.
16. Kumagai K, Motomura K, Egashira M, Tomita M,
Suzuki M, Uetani M, et al. A case of progressive
osseous heteroplasia: a first case in Japan. Skeletal
Radiol. 2008; 37(6):563-7.
17. Hou JW. Progressive osseous heteroplasia controlled
by intravenous administration of pamidronate. Am J
Med Genet A. 2006; 140(8):910-3.
18. Chan I, Hamada T, Hardman C, McGrath JA, Child FJ.
Progressive osseous heteroplasia resulting from a
new mutation in the GNAS1 gene. Clin Exp Dermatol.
2004; 29(1):77-80.